Product NDC: | 0087-6073 |
Proprietary Name: | GLUCOVANCE |
Non Proprietary Name: | GLYBURIDE AND METFORMIN HYDROCHLORIDE |
Active Ingredient(s): | 2.5; 500 mg/1; mg/1 & nbsp; GLYBURIDE AND METFORMIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0087-6073 |
Labeler Name: | Bristol-Myers Squibb Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021178 |
Marketing Category: | NDA |
Start Marketing Date: | 20081215 |
Package NDC: | 0087-6073-11 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0087-6073-11) |
NDC Code | 0087-6073-11 |
Proprietary Name | GLUCOVANCE |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0087-6073-11) |
Product NDC | 0087-6073 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | GLYBURIDE AND METFORMIN HYDROCHLORIDE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20081215 |
Marketing Category Name | NDA |
Labeler Name | Bristol-Myers Squibb Company |
Substance Name | GLYBURIDE; METFORMIN HYDROCHLORIDE |
Strength Number | 2.5; 500 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |